Biopharmaceuticals
Oncology
News Release - May 23, 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Source: Genentech
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.